Loss of TNF-α-regulated COX-2 expression in ovarian cancer cells

Oncogene

Volumn 24, Issue 54, 2005, Pages 7991-8002

  Yang, Wan Lin ^a   Roland, Isabelle H ^a   Godwin, Andrew K ^a   Xu, Xiang Xi ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Cyclooxygenases; Ovarian carcinomas; Ovarian epithelial cells; TNF

Indexed keywords

CYCLOOXYGENASE 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL; CARCINOGENESIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CYCLOOXYGENASE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 28544440746     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208943     Document Type: Article

References (72)

1. Akhmedkhanov AA, Toniolo P and Zeleninch-Jacquotte A. (2001). Soc. Gyn. Oncol., 80, 286.
2. Arnott CH, Scott KA, Moore RJ, Robinson SC, Thompson RG and Balkwill FR. (2004). Oncogene, 23, 1902-1910.
3. Baldwin AS. (1996). Annu. Rev. Immunol., 14, 649-683.
4. Barnes MN, Grizzle WE, Grubbs CJ and Partridge EE. (2002). CA Cancer J. Clin., 52, 216-225.
5. Barnes PJ and Karin M. (1997). N. Eng. J. Med., 336, 1066-1071.
6. Baud V and Karin M. (2001). Trends Cell Biol., 11, 372-377.
7. Boulton TG, Nye SH, Robbins DJ, IP NY, Radziejewska E, Morgenbesser SD, Depinho RA, Panayotatos N, Cobb MH and Yancopoulos GD. (1991). Cell, 65, 663-675.
8. Brannstrom M, Bonello N, Wang LJ and Norman RJ. (1995). Reprod. Fertil. Dev., 7, 67-73.
9. Chen G and Goeddel DV. (2002). Science, 296, 1634-1635.
10. Chun KS and Surh YJ. (2004). Biochem. Pharmacol., 68, 1089-1100.
11. Cramer D, Harlow B, Titus-Ernstaff L, Bohlke K, Welch WR and Greenberg ER. (1998). Lancet, 351, 104-107.
12. Davis BJ, Lennard DE, Lee CA, Tiano HF, Morham SG, Wetsel WC and Langenbach R. (1999). Endocrinology, 140, 2685-2695.
13. Denkert C, Kobel M, Pest S, Koch I, Berger S, Schwabe M, Siegert A, Reles A, Klosterhalfen B and Hauptmann S. (2002). Am. J. Path., 160, 893-903.
14. Dore M, Cote LC, Mitchell A and Sirois J. (1998). J. Histochem. Cytochem., 46, 77-84.
15. Downs SM and Longo FJ. (1982). Am. J. Anat., 164, 265-274.
16. Duffy DM and Stouffer RL. (2001). Mol. Hum. Reprod., 7, 731-739.
17. Espey LL. (1994). Biol. Reprod., 50, 233-238.
18. Ferrandina G, Ranelletti FO, Lauriola L, Fanfani F, Legge F, Mottolese M, Nicotra MR, Natali PG, Zakut VH and Scambia G. (2002). Gynecol. Oncol., 85, 305-310.
19. Fong CY, Pang L, Holland E and Knox AJ. (2000). Am. J. Physiol. Lung Cell Mol. Physiol., 279, L201-L207.
20. Ghosh S and Baltimore D. (1990). Nature, 344, 678-682.
21. Gupta RA, Tejada LV, Tong BJ, Das SK, Morrow JD, Dey SK and DuBois RN. (2003). Cancer Res., 63, 906-911.
22. Hamilton TC, Young RC, Louie KG, Behrens BC, McKoy WM, Grotzinger KR and Ozols RF. (1984). Cancer Res., 44, 5286-5290.
23. Howe LR and Dannenberg AJ. (2002). Semin. Oncol., 29, 111-119.
24. Hsu H, Xiong J and Goeddel DV. (1995). Cell, 81, 495-504.
25. Klimp AH, Hollema H, Kempinga C, van der Zee AG, de Vries EG and Daemen T. (2001). Cancer Res., 61, 7305-7309.
26. Komori A, Yatsunami J, Suganuma M, Okabe S, Abe S, Sakai A, Sasaki K and Fujiki H. (1993). Cancer Res., 53, 1982-1985.
27. Lal G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans JF and Gallinger S. (2001). Cancer Res., 61, 6131-6136.
28. Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT and Masferrer JL. (2002). Cancer Res., 62, 625-631.
29. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM and Dey SK. (1997). Cell, 91, 197-208.
30. Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF and Hla T. (2001). J. Biol. Chem., 276, 18563-18569.
31. Malik STA, Griffin DB, Fiers W and Balkwill FR. (1989). Int. J. Cancer, 44, 918-925.
32. Malik STA, Naylor MS, East N, Oliff A and Balkwill FR. (1990). Eur. J. Cancer, 26, 1031-1034.
33. Masferrer J. (2001). Cancer J. Suppl., 3, S144-S150.
34. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ and Seibert K. (2000). Cancer Res., 60, 1306-1311.
35. Matsumoto Y, Ishiko O, Deguchi M, Nakagawa E and Ogita S. (2001). Int. J. Mol. Med., 8, 31-36.
36. Moore BC and Simmons DL. (2000). Curr. Med. Chem., 7, 1131-1144.
37. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G and Balkwill F. (1999). Nat. Med., 5, 828-831.
38. Munkarah AR, Morris R, Baumann P, Deppe G, Malone J, Diamond MP and Saed GM. (2002). J. Soc. Gyn. Invest., 9, 168-173.
39. Murdoch WJ, Colgin DC and Ellis JA. (1997). J. Anim. Sci., 75, 1601-1605.
40. Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ and King PH. (2003). Cancer Res., 63, 4181-4187.
41. Nasi ML and Castiglione M. (2002). Ann. Oncol., 13, 1169-1171.
42. Ness RB and Cottreau C. (2000). J. Natl. Cancer Inst., 91, 1459-1467
43. Response: J. Natl. Cancer Inst., 92, 163, 2000.
44. Norman RJ. (2001). Lancet, 358, 1287-1288.
45. Okamura H, Fukumoto M and Mori T. (1985). Adv. Prostagl. Throm. Leuk. Res., 15, 597-599.
46. Old LJ. (1985). Science, 230, 630-632.
47. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF and Taketo MM. (1996). Cell, 87, 803-809.
48. Pall M, Friden BE and Brannstrom M. (2001). Hum. Reprod., 16, 1323-1328.
49. Prescott SM and Fitzpatrick FA. (2000). Biochim. Biophys. Acta, 1470, M69-M78.
50. Richards JS, Russell DL, Ochsner S and Espey LL. (2002). Annu. Rev. Physiol., 64, 69-92.
51. Rodriguez-Burford C, Barnes MN, Oelschlager DK, Myers RB, Talley LI, Partridge EE and Grizzle WE. (2002). Clin. Cancer Res., 8, 202-209.
52. Roland IH, Yang WL, Yang DH, Daly MB, Ozols RF, Hamilton TC, Lynch HT, Godwin AK and Xu XX. (2003). Cancer, 98, 2607-2623.
53. Schilder RJ, Hall L, Monks A, Handel LM, Fornace Jr AJ, Ozols RF, Fojo AT and Hamilton TC. (1990). Int. J. Cancer, 45, 416-422.
54. Shigemasa K, Tian X, Gu L, Shiroyama Y, Nagai N and Ohama K. (2003). Int. J. Oncol., 22, 99-105.
55. Siemens CH and Auersperg N. (1988). J. Cell. Physiol., 134, 347-356.
56. Singer CA, Baker KJ, McCaffrey A, AuCoin DP, Dechert MA and Gerthoffer WT. (2003). Am. J. Physiol. Lung Cell Mol. Physiol., 285, L1087-L1098.
57. Smith ER, Daly MB and Xu XX. (2004). CEBP, 13, 144-145.
58. Sorensen HT, Friis S, Norgard B, Mellemkjaer L, Blot WJ, McLaughlin JK, Ekbom A and Baron JA. (2003). Br. J. Cancer, 88, 1687-1692.
59. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK and Levin B. (2000). N. Engl. J. Med., 342, 1946-1952.
60. Subbaramaiah K and Dannenberg AJ. (2002). Trends Pharm. Sci., 24, 96-102.
61. Suganuma M, Okabe S, Marino NW, Sakai A, Sueoka E and Fujiki H. (1999). Cancer Res., 59, 4516-4518.
62. Terranova PF and Rice VM. (1997). Am. J. Reprod. Immun., 37, 50-63.
63. Tiano HF, Loftin CD, Akunda J, Lee CA, Spalding J, Sessoms A, Dunson DB, Rogan EG, Morham SG, Smart RC and Langenbach R. (2002). Cancer Res., 62, 3395-3401.
64. Tokuyama O, Nakamura Y, Muso A, Honda K, Ishiko O and Ogita S. (2001). Int. J. Mol. Med., 8, 603-606.
65. Trifan OC and Hla T. (2003). J. Cell. Mol. Med., 7, 207-222.
66. Tsafriri A and Reich R. (1999). Exp. Clin. Endoc. Diabetes, 107, 1-11.
67. Wang H, Ma WG, Tejada L, Zhang H, Morrow JD, Das SK and Dey SK. (2004). J. Biol. Chem., 279, 10649-10658.
68. Wang S and El-Deiry WS. (2003). Oncogene, 22, 8628-8633.
69. Williams CS, Mann M and DuBois RN. (1999). Oncogene, 18, 7908-7916.
70. Williams CS, Watson AJ, Sheng H, Helou R, Shao J and DuBois RN. (2000). Cancer Res., 60, 6045-6051.
71. Yang DH, Smith ER, Cohen C, Wu H, Patriotis C, Godwin AK, Hamilton TC and Xu XX. (2002). Cancer, 94, 2380-2392.
72. Yang WL, Godwin AK and Xu XX. (2004). Cancer Res., 64, 1534-1540.